EP3111217A1 - Composition à paire-fret de géométrie définie - Google Patents

Composition à paire-fret de géométrie définie

Info

Publication number
EP3111217A1
EP3111217A1 EP15706755.4A EP15706755A EP3111217A1 EP 3111217 A1 EP3111217 A1 EP 3111217A1 EP 15706755 A EP15706755 A EP 15706755A EP 3111217 A1 EP3111217 A1 EP 3111217A1
Authority
EP
European Patent Office
Prior art keywords
analyte
fret
acceptor
donor
linking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15706755.4A
Other languages
German (de)
English (en)
Inventor
Anne ENZENBERG
Christine Boeffel
André LASCHEWSKY
Erik Wischerhoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eV
Original Assignee
Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eV filed Critical Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eV
Publication of EP3111217A1 publication Critical patent/EP3111217A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent

Definitions

  • the present invention relates to a composition for the detection of an analyte.
  • recognition units usually antibodies
  • immobilized on a solid support serve as "catchers" for the antigen (the analyte) to be detected, and the presence of the analyte by a labeled secondary antibody is made visible to the naked eye Labeling reagent z.
  • gold nanoparticles or colored latex particles used. The principle is widely used commercially, e.g. In mass-produced items such as home-use pregnancy tests. However, it assumes that two different recognition groups are available per analyte.
  • Detection unit is bound, displaced by analyte molecules. Disadvantage here is that a clear proof of the binding events in small
  • Binding events is; on the other hand, the method is so far only for small
  • Analyte molecules such. As glucose applicable.
  • complementary Polynukleotidstrlinde be marked at positions that after base pairing (ie the recognition process) so close a distance that an efficient energy transfer can take place, see eg Didenko, V.V.
  • Donor-acceptor pairs are used, between which a radiation-free energy transfer can take place.
  • donor and acceptor may be different fluorophores.
  • the donor may be a fluorophore while the acceptor is a fluorescence quencher.
  • Assign donor and acceptor to the complementary Polynucleotide strands on a sufficiently small distance, so there is a radiation-free energy transfer from the donor to the acceptor.
  • the donor no longer shows fluorescence, while the acceptor either emits the transferred energy radiation-free and thus as
  • Wavelength fluoresces If the complementary Polynukleotidstrssene and thus donor and acceptor spatially separated from each other, is a
  • the method has the advantage of high sensitivity when one of the complementary polynucleotide strands carries one fluorescence quencher and the other is fluorescently labeled. If the strand with the fluorescence quencher is then displaced from a sample by a more strongly binding unlabelled DNA / RNA sequence, this manifests itself in the transition from a dark to a fluorescent state. Such transitions are visually very easy to detect.
  • an analyte preferably in the field of biology, medicine or biochemistry
  • composition for the detection of an analyte comprising
  • At least one linking moiety formed by an at least bifunctional molecule i.e., a molecule having at least two functional groups
  • Linking unit connects the FRET donor and the FRET acceptor
  • Linking unit is connected.
  • an at least bifunctional molecule i.e., a molecule having at least two functional groups
  • This created by the at least bifunctional molecule hereinafter also referred to as linking molecule
  • Linking unit brings donor and acceptor of the FRET pair into a defined spatial proximity, so that a radiation-free energy transfer can take place.
  • a functional group of the linking molecule may be sufficient to allow attachment of the FRET pair (e.g., in the case of a cyclic acid anhydride group or a
  • Epoxide there is at least one second functional group for a further reaction, for example, to allow a connection to a substrate (for example, a polymer).
  • a substrate for example, a polymer
  • the composition either lacks fluorescence (i.e., acceptor is a quencher) or luminesces in the wavelength characteristic of the acceptor. Since either the donor or the acceptor is linked to the linking moiety via an analyte-specific recognition moiety and an analyte-competitive binder interacting with this analyte-specific recognition moiety, the presence of the analyte and its interaction with the analyte-specific recognition moiety may provide donor release or acceptor of the linking unit effect. This leads to a spatial separation of the FRET donor-acceptor pair, whereby the
  • Luminescence radiation of the donor is reactivated in the presence of the analyte.
  • the composition according to the invention preferably also comprises a substrate, wherein the linking unit formed by the at least bifunctional molecule is connected to this substrate.
  • the linking unit formed from the at least bifunctional molecule combines donor, acceptor and substrate with each other. If either the donor or alternatively the acceptor is separated from the linking unit in the presence of the analyte, the remaining component of the FRET pair remains immobilized on the substrate.
  • the substrate may be, for example, a polymer or a solid surface.
  • the polymer may for example be immobilized on a solid surface (eg in the form of a coating).
  • FRET Förster resonance energy transfer
  • the donor of the FRET pair is a luminophore (e.g., an organic or inorganic fluorophore or an organic or inorganic phosphorescent component) that, when excited, transfers energy to the acceptor without radiation, provided donor and acceptor are sufficiently close. The distance in which a radiation-free luminophore (e.g., an organic or inorganic fluorophore or an organic or inorganic phosphorescent component) that, when excited, transfers energy to the acceptor without radiation, provided donor and acceptor are sufficiently close. The distance in which a radiation-free
  • Resonance energy transfer between donor and acceptor is still possible, can be up to a few nanometers.
  • a suitable distance of a given FRET donor-acceptor pair in which radiation-free resonance energy transfer is still possible is either basically known to the person skilled in the art (for example based on known Förster radii or Förster distances) or can be determined by the person skilled in the art via routine experiments.
  • the acceptor may also be a luminophore or else a luminescence quencher (for example a fluorescence quencher), ie a component which does not emit the energy transferred to it in the form of luminescence.
  • a luminescence quencher for example a fluorescence quencher
  • the donor may be an organic or inorganic luminophore.
  • luminophore may be fluorescent (i.e., a fluorophore)
  • FRET donor capable of exhibiting fluorescence
  • fluorescent dyes such as Xanthene dyes (for example, povhodamine, fluorescein), naphthalimides, coumarins, cyanine dyes, oxazines, pyrenes, porphyrins, acridines, conjugated oligomers, or polymers (ie, oligomers or conjugated polymers)
  • Double bonds e.g. Oligothiophene are called.
  • Fluorescent dyes can be obtained commercially or by conventional synthesis methods known to those skilled in the art.
  • Fluorescent nanoparticles for example fluorescent semiconducting nanoparticles or fluorescent quantum dots, can also be used as donors in the FRET pair.
  • nanoparticles containing CdSE, CdS or indium phosphide may be mentioned as fluorescent nanoparticles.
  • the average diameter of such fluorescent nanoparticles can vary over a wide range and is, for example, 1 nm-15 nm or even 1.5 nm-10 nm.
  • Such fluorescent nanoparticles are available commercially or by conventional production methods known to the person skilled in the art.
  • a suitable FRET donor which can show phosphorescence, is also basically known to the person skilled in the art.
  • tris [2- (4-methylphenyl) pyridyl] iridium, tris [9,9-dihexyl-2-pyridinyl-2 ') fluorenyl] iridium and phosphorescent nanoparticles such as e.g. ZnS nanoparticles are called.
  • the mean diameter of phosphorescent nanoparticles can vary over a wide range and is for example 1 nm-15 nm or even 1.5 nm-10 nm.
  • the acceptor of the FRET pair may be a luminophore or a luminescent extinguisher.
  • Suitable luminophores which can function as acceptors in a FRET pair are generally known to the person skilled in the art.
  • donor and acceptor are different.
  • donor and acceptor are so selected that the wavelengths of the luminescence emitted by the donor and acceptor (eg fluorescence radiation or phosphorescence) as much as possible differ and the wavelength difference thus preferably by the viewer with the naked eye is perceptible.
  • the acceptor is a luminescence extinguisher (eg, fluorescence quencher or phosphorescence quencher), ie, a component that does not emit luminescent radiation.
  • Suitable fluorescence quenchers are, for example, metal nanoparticles such as gold nanoparticles, silver nanoparticles, organic compounds containing viologen structures, or organic compounds containing nitroaromatics.
  • the mean diameter of nanoparticles that act as luminescence quenchers can vary over a wide range, for example, 1 - 10 nm.
  • the composition of the invention contains at least one linking moiety formed by an at least bifunctional molecule (i.e., a molecule having at least two functional groups).
  • an at least bifunctional molecule i.e., a molecule having at least two functional groups.
  • Linking unit is connected via an analyte-specific recognition unit and an analyte-competitive binder interacting with this analyte-specific recognition unit. It is preferably in the
  • a functional group may be sufficient (for example a
  • Paares can also be done via two functional groups. Furthermore, a functional group of the linking molecule may be sufficient to control the
  • the attachment to the substrate may also be via two or more functional groups (for example, two OH groups in the linking molecule, via a polycondensation cause incorporation of the linking molecule into a polymer chain).
  • the linking molecule contains 2-4 or 2-3 functional groups.
  • the person skilled in the art knows (for example from known Förster radii or distances for certain FRET pairs) or the skilled person can use routine experiments to determine up to which distance between donor and acceptor a resonance energy transfer is still possible.
  • the skilled person can select at least bifunctional molecules of suitable size, which ensure that donor and acceptor after their attachment to the
  • Linking unit are not too far apart.
  • it may be a molecule in which the respective distance between the functional groups is smaller than the Förster radius or Förster distance or even smaller than half the Förster radius of the used FRET donor acceptor pair.
  • the linking molecule is a molecule (preferably an organic molecule) of relatively low molecular weight, for example a molecular weight of less than 300 g / mol or less than 250 g / mol or even less than 200 g / mol.
  • Suitable functional groups of the linking molecule can be readily selected by one skilled in the art. It may be, for example, a functional group containing one or more heteroatoms (e.g., O, N, or S), or a carbon-carbon double bond or triple bond. Exemplary functional groups are carboxylic acids or their salts, acid anhydrides (preferably cyclic
  • Acid anhydride groups hydroxy (alcohols or phenols), thiol, amino or ether groups (preferably cyclic ether groups such as epoxide),
  • linking at least bifunctional molecules from which the linking moiety is obtained in the composition, functional amino acids (such as serine lysine, asparagine, glutamine or cysteine), functional epoxides (such as glycidyl methacrylate), functional anhydrides, e.g. Maleic anhydride, itaconic anhydride or allylsuccinic anhydride, and acrylic compounds such as e.g. B. 2-acrylamido-2-hydroxyacetic acid.
  • functional amino acids such as serine lysine, asparagine, glutamine or cysteine
  • functional epoxides such as glycidyl methacrylate
  • functional anhydrides e.g. Maleic anhydride, itaconic anhydride or allylsuccinic anhydride
  • acrylic compounds such as e.g. B. 2-acrylamido-2-hydroxyacetic acid.
  • the donor or the acceptor is linked to the linking moiety via an analyte-specific recognition moiety and an analyte-competitive binder, the presence of the analyte and its interaction with the analyte-specific recognition moiety can cause the donor or acceptor to detach from the linking moiety.
  • analyte to be detected is determined, one of ordinary skill in the art may choose a suitable analyte-specific one
  • Select detection unit Exemplary, smaller groups such as biotin, sugar, amino acids, but also larger units such as peptides, proteins, polysaccharides, antibodies, F a b fragments of antibodies, enzymes,
  • Enzyme fragments are used as recognition units, especially for the detection of
  • analyte-competitive binders in conjunction with analyte-specific recognition units and analytes is known in principle to the person skilled in the art from displacement assays or competitive assays.
  • the skilled person on the basis of his general knowledge, can select not only a suitable analyte-specific recognition unit but also a suitable analyte-competitive binding agent.
  • exemplary competitive binders include, but are not limited to, smaller groups such as biotin, sugars, amino acids, nucleic acids, as well as peptides, proteins, nucleotides,
  • Oligosaccharides or polysaccharides are called.
  • the FRET donor and the analyte-specific recognition unit are covalently bound to the linking unit, the analyte-competitive binder is labeled with the FRET acceptor and, through its interaction with the analyte-specific recognition unit, connects the FRET acceptor to the linking moiety.
  • Labeling of the analyte-competitive binder with the FRET actor can be accomplished by linking these two components together via a covalent linkage.
  • these two components may also be non-covalently linked together (for example, one or more analyte-competitive binders present on the surface of a nanoparticle functioning as a FRET acceptor).
  • the FRET donor and the analyte-competitive binder are covalently bound to the linking moiety, the analyte-specific
  • Recognition unit with the FRET actor can be done by connecting these two components together via a covalent connection.
  • these two components may also be non-covalently linked together (for example one or more analyte-specific
  • Recognition units present on the surface of a nanoparticle acting as a FRET acceptor).
  • the FRET acceptor and the analyte-specific recognition moiety are covalently bound to the linking moiety, the analyte-competitive binder is labeled with the FRET donor and through its
  • Binders with the FRET donor can be made by connecting these two components together via a covalent bond.
  • these two components may also be non-covalently bonded together
  • analyte-competitive binders present on the surface of a FRET donor nanoparticle.
  • the FRET acceptor and the analyte-competitive binder are covalently bound to the linking moiety, the analyte-specific recognition moiety is labeled with the FRET donor, and by their
  • Recognition unit with the FRET donor can be made by connecting these two components together via a covalent connection.
  • these two components may also be non-covalently linked together (for example one or more analyte-specific
  • Recognition units present on the surface of a nanoparticle acting as a FRET donor).
  • composition according to the invention can in principle be used for the detection of a large number of different analytes.
  • Preferred analytes are, for example, bio-oligomers, biopolymers or biological particles.
  • Exemplary bio-oligomers are oligopeptides, oligosaccharides and oligonucleotides.
  • Exemplary biopolymers are polypeptides, proteins, polysaccharides, polynucleotides and nucleic acids.
  • Exemplary biological particles are viruses and bacteria.
  • the linking unit formed by the at least bifunctional molecule is preferably also connected to a substrate and thereby immobilizes the FRET donor-acceptor pair.
  • the substrate is covalently linked to the linking moiety by a reaction with one of the functional groups of the at least bifunctional molecule.
  • the substrate may be, for example, an organic or inorganic polymer. It can also be a solid surface. If the substrate is a polymer, it may be preferable to immobilize this polymer again on a solid surface.
  • This direct or indirect (eg via the polymer applied to the solid surface) immobilization offers the advantage that the acceptor displaced by the analyte (or alternatively the donor displaced by the analyte) can be completely removed from the system by rinsing. Thus, loss of intensity can be avoided by the then freely displaceable displaced acceptor accidentally gets back into the immediate vicinity of the donor.
  • the linking unit is as
  • the donor and the acceptor can be connected to the at least bifunctional molecule and this molecule already carrying the FRET donor-acceptor pair is subsequently polymerized together with other monomers.
  • this molecule already carrying the FRET donor-acceptor pair is subsequently polymerized together with other monomers.
  • Recognition unit (alternatively: the analyte-competitive binder) to covalently bind to the linking molecule, then polymerize this molecule with other monomers and then add to the analyte-competitive binder (covalent or non-covalent) FRET acceptor. Due to the high detection sensitivity of the composition according to the invention, the proportion of monomers having a FRET donor-acceptor pair or initially only the FRET donor or FRET acceptor, can be kept quite low, for example less than 5 mol% or even less as 2 mole%, based on the total amount of monomers.
  • the at least bifunctional molecule is to be polymerized into a polymer chain
  • at least one of the functional groups is a polymerizable group, for example, a carbon-carbon double bond.
  • the linking molecule still has another functional group and the polymerization is realized with the participation of this further functional group (for example a polycondensation which requires the presence of two OH groups in the linking molecule).
  • the linking unit carrying the FRET donor-acceptor pair may be present as a repeating unit in a variety of different polymers.
  • vinyl polymers such as e.g. Polyvinylpyrrolidones or
  • Polyvinylcaprolactams polyacrylamides, polyvinyl alcohols, polyolefms such as
  • Polyethylene or polypropylene or poly (meth) acrylates may be mentioned.
  • the polymer may also be a hydrogel. This can optionally be cross-linked.
  • the hydrogel may optionally also be a responsive hydrogel, for example a thermoresponsive hydrogel.
  • linking unit carrying the FRET donor-acceptor pair may be grafted onto a polymer chain.
  • possible polymers reference may be made to the above statements.
  • the polymer in which the linking unit is present as a repeating unit, or on which the linking unit is grafted, can on a
  • the linking unit can be connected to a variety of different
  • Bonded solid surfaces can be both organic (eg a polymer) and inorganic solid surfaces. If reactive groups are present on a solid surface (for example, a functionalized surface with reactive groups such as -NH 2 , -SH, -OH, -COOH or epoxy), these may have a functional group of at least Reacting bifunctional molecule and thus realize a covalent connection of the linking unit with the substrate.
  • a solid surface for example, a functionalized surface with reactive groups such as -NH 2 , -SH, -OH, -COOH or epoxy
  • the linking unit is as
  • Solid surface e.g., in the form of a polymer coating.
  • Molecule obtained moiety 001 which combines a polymer 002, a FRET donor 003 and FRET acceptor 004.
  • the FRET donor 003 may be a fluorophore.
  • the connection of the FRET acceptor 004 with the linking unit 001 is mediated via a competitive binder 005 and an analyte-specific recognition unit 006.
  • Analyte-specific recognition unit 006 is covalently bound to linking unit 001 and interacts with analyte-competitive binder 005, which in turn is linked to FRET acceptor 004.
  • the FRET acceptor 004 may be, for example, a gold nanoparticle, on the
  • the competitive binder 005 is present and mediated by its interaction with the detection unit 006, the connection of the FRET -Aceptor 004 with the linking unit 001.
  • the linking unit 001 formed from the at least bifunctional molecule donor 003 and acceptor 004 are kept at a defined distance, which is sufficiently low for a
  • the composition does not fluoresce in this state.
  • the fluorescence quencher FRET acceptor 004 is used together with the analyte-competitive binder 005 present on its surface is separated from the linking unit 001.
  • the FRET pair is disconnected
  • the left half shows a linking unit 001 obtained from an at least bifunctional molecule which connects a polymer 002, a FRET donor 003 and FRET acceptor 004.
  • the compound of the acceptor 004 which acts as a fluorescence quencher, with the
  • Linking unit 001 mediated via an analyte-specific recognition unit 006 and an analyte-competitive binder 005.
  • the analyte-competitive binder 005 is covalently bound to the linking unit 001, while analyte-specific recognition unit 006 is bound to the acceptor 004.
  • this displaces the analyte-competitive binder 005 from the analyte-specific recognition unit 006, as a result of which the acceptor 004 is separated from the linking unit 001.
  • This is shown in the right half of Figure lb.
  • the FRET pair is disconnected, energy transfer from donor 003 to acceptor 004 is no longer possible, and the fluorescence of donor 003 is activated.
  • the present invention relates to a method of making the above-described composition
  • a method of making the above-described composition comprising attaching a FRET donor and a FRET acceptor to an at least bifunctional molecule, wherein either the attachment of the FRET acceptor or the attachment of the FRET donor to the at least bifunctional molecule via an analyte-specific recognition unit and an analyte-competitive binder.
  • the method further comprises the attachment of the at least bifunctional molecule to a substrate.
  • the FRET donor and analyte-specific recognition moiety react (either simultaneously or sequentially) with the at least bifunctional molecule, followed by the addition of the analyte-competitive binding agent (covalent or non-covalent) with the FRET acceptor is marked. Since the analyte-competitive binder with the analyte-specific
  • Components ie analyte-competitive binders and analyte-specific
  • the at least bifunctional molecule is linked to a substrate via another functional group, for example in a polymerization reaction and by grafting onto a polymer.
  • the timing of this attachment to the substrate can be varied.
  • the at least bifunctional molecule can first be bound to the substrate, followed by attachment of the FRET donor and the FRET acceptor to the linking molecule.
  • the FRET donor and the analyte-specific recognition unit can be bound to the at least bifunctional molecule, followed by attachment of the linking molecule to the substrate (eg, by polymerization or grafting) and then addition of the analyte-competitive binder, the (covalent or non-covalent) with the FRET
  • the FRET donor and the analyte-competitive binder react with the at least bifunctional molecule, followed by the addition of the analyte-specific
  • Components ie analyte-competitive binders and analyte-specific
  • the at least bifunctional molecule is linked to a substrate via another functional group, for example in a polymerization reaction and by grafting onto a polymer.
  • the timing of this attachment to the substrate can be varied.
  • the at least bifunctional molecule can first be bound to the substrate, followed by attachment of the FRET donor and the FRET acceptor to the linking molecule.
  • the FRET donor and the analyte-competitive binder can be bound to the at least bifunctional molecule, followed by attachment of the linking molecule to the substrate (eg, by polymerization or grafting) and then addition of the labeled with the FRET acceptor Analyte-specific detection unit.
  • the FRET acceptor and the analyte-specific recognition moiety react with the at least bifunctional molecule, followed by the addition of the analyte-competitive binding agent (covalent or non-covalent) with the FRET -Donor is marked. Since the analyte-competitive binder interacts with the analyte-specific recognition unit, the FRET donor is via these two components, ie analyte-competitive binder and analyte-specific recognition unit, with the
  • the at least bifunctional molecule is linked to a substrate via another functional group, for example in a polymerization reaction and by grafting onto a polymer.
  • Time for this attachment to the substrate can be varied.
  • the at least bifunctional molecule can first be bound to the substrate, followed by attachment of the FRET acceptor and the FRET donor to the linking molecule.
  • the FRET acceptor and the analyte-specific recognition unit are bound to the at least bifunctional molecule, followed by the attachment of the linking molecule to the substrate (eg by polymerization or
  • the FRET acceptor and the analyte-competitive binder may react (either simultaneously or sequentially) with the at least bifunctional molecule, followed by the addition of the analyte-specific recognition moiety labeled with the FRET donor.
  • the FRET donor is connected to the linking molecule via these two components, ie analyte-competitive binder and analyte-specific recognition unit.
  • the at least bifunctional molecule is connected via a further functional group with a substrate, for example in one
  • the timing of this attachment to the substrate can be varied.
  • the at least bifunctional molecule can first be bound to the substrate and then followed by attachment of the FRET acceptor and the FRET donor to the linking molecule.
  • the FRET acceptor and the analyte-competitive binder can be bound to the at least bifunctional molecule, followed by attachment of the linking molecule to the substrate (eg, by polymerization or grafting) and then addition of the labeled with the FRET donor analyte-specific
  • the present invention relates to a device for detecting an analyte, the device being that described above
  • composition contains.
  • the device according to the invention may also comprise further device elements which are customary for this type of device, for example a signal converter and / or an electrical amplifier.
  • the composition according to the invention exhibits a marked change in the luminescence behavior upon attachment of the analyte to the detection unit, which can also be clearly visible to the naked eye, it is possible within the scope of the present invention for the device to have neither a
  • Signal converter still has an electrical amplifier.
  • the present invention relates to the use of the above-described composition for the detection of an analyte.
  • composition according to the invention can in principle be used for the detection of a large number of different analytes.
  • Preferred analytes are, for example, bio-oligomers, biopolymers or biological particles.
  • Exemplary bio-oligomers are oligopeptides, oligosaccharides and oligonucleotides.
  • Exemplary biopolymers are polypeptides, proteins, polysaccharides, polynucleotides and nucleic acids.
  • Exemplary biological particles are viruses and bacteria.
  • composition labeling of the analyte is not required.
  • the use therefore preferably takes place for the detection of an unlabelled analyte.
  • maleic anhydride acts as a bifunctional molecule which in the composition forms the linking moiety for acceptor, donor and substrate.
  • the FRET donor is rhodamine B (a fluorescent dye).
  • Gold nanoparticles act as a fluorescence-quenching FRET acceptor.
  • the rhodamine dye is covalently bound to the maleic anhydride.
  • Amantadine hydrochloride is used as test analyte.
  • the acceptor i.e., a gold nanoparticle
  • the acceptor is analyte-specific
  • Linking unit connected.
  • analyte-specific recognition unit cyclodextrin
  • adamantane acts as an analyte-competitive binder.
  • the analyte-competitive binder is covalently bound to the maleic anhydride.
  • the cyclodextrin is immobilized on the surface of the gold nanoparticles, yielding an analyte-specific recognition unit (cyclodextrin) labeled with the FRET acceptor (ie, gold nanoparticle).
  • the gold nanoparticle ie the acceptor
  • the acceptor ie, the gold nanoparticle
  • the acceptor is detached from the linking moiety because it becomes stronger between the analyte-specific recognition moiety and the analyte Interaction occurs as between the analyte-specific recognition group and the analyte-competitive binder.
  • the fluorophore pvhodamine B was chosen as the FRET donor.
  • the synthesis of rhodamine B-piperazine precursor 1 for attachment to maleic anhydride has been described in the literature [Nguyen, T .; Francis, M. B. Organic Letters 2003, 5, 3245.].
  • Rhodamine B-piperazine 1 is reacted with maleic anhydride to give rhodamine B- (3-carboxyacryloyl) -piperazine 2.
  • Rhodamine B-piperazine 1 (2 g, 3.66 mmol, 1 eq.) And maleic anhydride (0.36 g, 3.66 mmol, 1 eq.) are dissolved in 40 mL DMF / CH 2 Cl 2 2: 1 and 48 h at
  • Aminomethyladamantane attached to the second carboxylic acid function of the maleic acid spacer.
  • Rhodamine B (3-carboxyacryloyl) piperazine 2 (0.45 g, 0.70 mmol, 1 eq.) And 1 - [bis (dimethylamino) methylene] -1H-1,2,3-triazolo [4,5- b] Pyridinium 3-oxide hexafluorophosphate (HATU) (0.4 g, 1.05 mmol, 1.5 eq.) is dissolved in 10 mL of dry CH 2 Cl 2 under argon.
  • HATU Pyridinium 3-oxide hexafluorophosphate
  • DIEA Diisopropylethylamine
  • 1-adamantylmethylamine (0.13 g, 86 ⁇ , 0.77 mmol, 1.1 eq .)
  • reaction mixture is shaken out against 3 ⁇ 0.1 mol / L HCl.
  • organic phase is dried over Na 2 S0 4 and the solvent removed.
  • the residue is dissolved in a little methanol and precipitated with a large excess of diethyl ether.
  • the solid is filtered off with suction and dried in vacuo.
  • the linking molecule is incorporated into a polymer backbone via the polymerizable double bond of maleic acid.
  • Another possibility for immobilization may be, for example, attachment to a functionalized surface (NH 2 , SH, COOH, epoxy).
  • Maleic acid monomers can be mixed with various
  • Monomers are copolymerized for immobilization (including N-vinylpyrrolidone, N-vinylcaprolactam, N-isopropylacrylamide).
  • the polymers thus prepared can also be converted to hydrogels with the aid of cross-linking agents.
  • the double bond of maleic acid can be reacted with different surface-bound nucleophiles (NH 2 -, SH-).
  • N-vinylpyrrolidone, rhodamine B-piperazine-maleamic acid-methyladamantane 3 (0.1-1 mol%) and azo-bis (isobutyronitrile) AIBN (1 mol%) are dissolved in methanol (25% by weight solids content) and stirred for 15 min Purged argon. It is heated to 60 ° C oil bath temperature and polymerized for 24 h. The mixture is then dialysed against water for 7 days (M w 12000-14000 g / mol) and the resulting polymer is freeze-dried.
  • Au NP gold nanoparticles
  • ⁇ -CD ⁇ -cyclodextrins
  • the FRET acceptor i.e., the gold nanoparticle is linked to the linking moiety formed from the maleic anhydride.
  • the prepared polymers described in C serve as a matrix for the
  • the FRET acceptor i.e., the gold nanoparticle
  • the linking moiety Since the FRET donor (rhodamine fluorophore) and FRET acceptor (gold nanoparticles) are kept within a defined small distance by the linking unit formed from the maleic anhydride, a radiation-free resonance energy transfer and thus a
  • FIG. 3 shows the course of the fluorescence intensity upon the addition of Au nanoparticles which have been functionalized with PVP. Since PVP in Compared to cyclodextrin no significant interaction with the as
  • the ß-CD-Au NPs show a significantly higher quenching efficiency compared to PVP Au NPs.
  • this sensor can be used for a variety of binding partners and not limited to a few binding pairs. This offers a great
  • Sensitivity of detection is essential.
  • the efficiency of the fluorescence quenching in the example given here is almost 50% higher for the fluorescence quencher labeled with the detection unit than for the reference fluorescence quencher without detection unit. Since analyte and recognition unit are variably exchangeable, a fluorescence quenching assay can be synthesized which is not fixed to the sequence of defined biological sequences. By adding the analyte to the non-fluorescent state, the
  • Fluorescence quencher are displaced and the fluorescence amplified again.
  • Figure 4 shows the fluorescence enhancement as a function of time after addition of the analyte amantadine hydrochloride. Because this analyte is a stronger
  • the FRET donor 003 and the competitive binder 005 are covalently bonded to the linking unit 001 formed from the at least bifunctional molecule.
  • the linking unit 001 is also bonded to a polymer 002. Since no FRET acceptor is present, the FRET donor 003 fluoresces and thus the composition (vessel A). This is followed by the addition of gold nanoparticles, on the surface of which cyclodextrin is immobilized.
  • Gold nanoparticles act as fluorescence-quenching FRET acceptors 004 and the cyclodextrin acts as an analyte-specific recognition unit 006 (i.e., an analyte-specific recognition unit 006 labeled with a FRET acceptor 004).
  • the FRET acceptor 004 is bound to the linking unit 001. Due to the connection to the linking unit 001 are FRET donor 003 and FRET acceptor 004 at a defined distance, which is low enough for the radiation-free
  • Composition no longer fluoresces (vessel B). Becomes an analyte 007

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

L'invention concerne une composition servant à la détection d'analytes, qui comprend : au moins une paire donneur-accepteur de FRET, au moins un motif de liaison qui est formé d'au moins une molécule bifonctionnelle, le motif de liaison formé de la au moins une molécule bifonctionnelle liant le donneur et l'accepteur l'un à l'autre, et soit le donneur soit l'accepteur étant lié au motif de liaison par le biais d'un motif d'identification spécifique de l'analyte et d'un liant compétitif avec l'analyte.
EP15706755.4A 2014-02-24 2015-02-19 Composition à paire-fret de géométrie définie Withdrawn EP3111217A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102014203266.0A DE102014203266B4 (de) 2014-02-24 2014-02-24 Zusammensetzung mit FRET-Paar in definierter Geometrie
PCT/EP2015/053529 WO2015124690A1 (fr) 2014-02-24 2015-02-19 Composition à paire-fret de géométrie définie

Publications (1)

Publication Number Publication Date
EP3111217A1 true EP3111217A1 (fr) 2017-01-04

Family

ID=52595305

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15706755.4A Withdrawn EP3111217A1 (fr) 2014-02-24 2015-02-19 Composition à paire-fret de géométrie définie

Country Status (3)

Country Link
EP (1) EP3111217A1 (fr)
DE (1) DE102014203266B4 (fr)
WO (1) WO2015124690A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102015225457B4 (de) * 2015-12-16 2017-07-20 BSH Hausgeräte GmbH Sensorvorrichtung zum Bestimmen zumindest einer Eigenschaft einer Flüssigkeit, wasserführendes Haushaltsgerät mit der Sensorvorrichtung sowie Verfahren zum Bestimmen zumindest einer Eigenschaft einer Flüssigkeit
DE102016221875B4 (de) 2016-11-08 2018-06-28 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Stationäre Phase zur Detektion eines bestimmten Analyten in einem Gemisch, Verwendungen hiervon und Verfahren zur Detektion eines bestimmten Analyten in einem Gemisch
EP3373009B1 (fr) * 2017-03-07 2021-09-01 Karlsruher Institut für Technologie Composés fluorescents pour la détection de mélanome malin

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2291730A1 (fr) 1997-06-05 1998-12-10 Kairos Scientific Inc. Etalonnage du transfert d'energie de resonance par fluorescence en microscopie
WO1999029894A1 (fr) 1997-12-05 1999-06-17 Pharmacia & Upjohn Company Essais de criblage a haut rendement a base de fluorescence pour proteines kinases et phosphatases
EP1154991B1 (fr) 1999-02-18 2004-07-28 The Regents of the University of California Complexes salicylamides lanthanides utilises comme marqueurs luminescents
ATE285394T1 (de) 1999-02-18 2005-01-15 Univ California Phthalamid-lanthanid komplexe zur verwendung als lumineszenzmarker
WO2000064988A1 (fr) 1999-04-23 2000-11-02 Molecular Probes, Inc. Colorants a base de xanthene et leur utilisation en tant que composes d'extinction de luminescence
GB9926336D0 (en) * 1999-11-05 2000-01-12 Isis Innovation Universal flourescent sensors
AU2001234709A1 (en) * 2000-01-31 2001-08-07 Board Of Regents, The University Of Texas System Method of preparing a sensor array
DE10108263A1 (de) 2001-02-21 2002-09-05 Max Planck Gesellschaft Analyse von Modifizierungen und Demodifizierungen von Proteinen mit Ubiquitinverwandten Proteinen mittels FRET (Fluorescence Resonance Energy Transfer)
ATE365211T1 (de) 2001-08-20 2007-07-15 Regenesis Bioremediation Produ Biosensor für kleinmolekulare analyten
DE10153829A1 (de) 2001-11-05 2003-05-28 Bayer Ag Assay basierend auf dotierten Nanoteilchen
WO2004068115A2 (fr) 2003-01-30 2004-08-12 Bellbrook Labs, Llc Procede relatif a des essais de reactions a transfert de groupe
ATE346898T1 (de) 2003-04-30 2006-12-15 Nanosolutions Gmbh Kern-mantel nanoteilchen für (f) ret- testverfahren
DE10343375A1 (de) 2003-09-17 2005-04-28 Axaron Bioscience Ag Verfahren zur Detektion und Analyse von Protein-Protein-Interaktionen
US7282339B2 (en) * 2003-09-17 2007-10-16 Invitrogen Corporation Competitive immunoassay
US7795009B2 (en) * 2005-06-15 2010-09-14 Saint Louis University Three-component biosensors for detecting macromolecules and other analytes
WO2007016665A2 (fr) 2005-07-29 2007-02-08 Dominion Diagnostics, Llc Dosages par fluorescence a usage unique servant a determiner des substances a analyser
JP2007040834A (ja) * 2005-08-03 2007-02-15 Japan Science & Technology Agency 免疫測定用試薬
DE102005051978A1 (de) 2005-10-31 2007-05-10 Forschungszentrum Borstel Zentrum für Medizin und Biowissenschaften Verfahren zur Bestimmung der Spaltbarkeit von Substraten
DE102007018833A1 (de) 2007-04-20 2008-10-23 Febit Holding Gmbh Verbesserte molekularbiologische Prozessanlage
JP5264421B2 (ja) * 2007-11-22 2013-08-14 富士フイルム株式会社 被験物測定用担体およびその製造方法
DE102010025496A1 (de) 2009-10-09 2011-04-21 Universität Duisburg-Essen Verfahren zur Detektion von Genveränderungen, insbesondere Mutationen

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
None *
See also references of WO2015124690A1 *

Also Published As

Publication number Publication date
DE102014203266B4 (de) 2018-07-19
WO2015124690A1 (fr) 2015-08-27
DE102014203266A1 (de) 2015-08-27

Similar Documents

Publication Publication Date Title
DE10042023C2 (de) Kapseln, die feste Teilchen signalerzeugender Substanzen einkapseln, und deren Verwendung bei Bioassays zum Nachweis von Zielmolekülen in einer Probe
DE3685600T2 (de) Stabilisierte fluoreszierende seltenerd-indikatoren und physiologisch-reaktive kennsatz-spezies.
DE102006016014A1 (de) Vorrichtung und Verfahren zur Detektion von biologischen Molekülen
DE69419461T2 (de) Vorrichtung zum Auffangen von zielmolekülen und diese Vorrichtung benutzendes Auffangverfahren
DE69728017T2 (de) Vorrichtungen und Verfahren zur Erkennung von mehreren Analyten in Proben
EP1196780B1 (fr) Production et utilisation de microparticules et de nanoparticules luminescentes
EP0612772B1 (fr) Copolymères luminescents
DE10137530A1 (de) Anordnung und Verfahren zur Mehrfach-Fluoreszenzmessung
EP1444517A2 (fr) Analyse reposant sur des nanoparticules dopees
WO2002093504A2 (fr) Fil de securite pour le marquage infalsifiable d'objets
WO2004014540A9 (fr) Microcapsules couche par couche a codes de couleurs servant de bibliotheques d'analyse combinatoires et de capteurs optiques specifiques
EP3111217A1 (fr) Composition à paire-fret de géométrie définie
EP1332365B1 (fr) Procede et necessaire d'essai pour la detection d'analytes dans un echantillon
DE68924517T2 (de) Wässerige Suspension für diagnostischen Test.
DE19903576C2 (de) Quantitative Bestimmung von Analyten in einem heterogenen System
DE10030798A1 (de) Kompetitives Assay-Verfahren
DE60033665T2 (de) Gemusterte Polymeroberflächen geeignet für Biokonjugationen und Verfahren zu ihrer Herstellung
EP1963441B1 (fr) Polyelektrolytes monocouches ou multicouches pour des transducteurs de signaux optiques
DE102011085473A1 (de) Verfahren zur Identifikation von Aptameren
EP1627078A1 (fr) Procede d'immobilisation covalente de biomolecules de sonde sur des surfaces organiques
DE60105399T2 (de) Analyse von biologischen zielmolekülen unter verwendung eines einen fluoreszenzmarker tragenden biochips
DE102005056639A1 (de) Verfahren, Vorrichtung und Kit zur Untersuchung von Makromolekülen in einer Probe
DE102005010096B3 (de) Assay mit osmotisch induzierter Abtrennung und Anreicherung hochmolekularer nachzuweisender Substanzen und fluidisches Mikrosystem zu seiner Durchführung
DE102004048685A1 (de) Verfahren zum Nachweis von Biopolymeren, Biochips, Verfahren zur Immobilisierung von Antikörpern und Substrate auf denen Antikörper immobilisiert sind
DE102006003603A1 (de) Vernetzbare multifunktionelle Träger für (niedermolekulare) Liganden und deren Anwendung in der Analytik sowie Verfahren zu deren Herstellung und Vernetzung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20160907

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20180418

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BOEFFEL, CHRISTINE

Inventor name: LASCHEWSKY, ANDRE

Inventor name: WISCHERHOFF, ERIK

Inventor name: ENZENBERG, ANNE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180829